Daily Bulletin

Men's Weekly

.

Prota Therapeutics Achieves Peanut Allergy Treatment Milestone: Groundbreaking Clinical Trial Data Demonstrates Clinical Remission of Peanut Allergy in Paediatric Patients

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
Prota Therapeutics Achieves Peanut Allergy Treatment Milestone: Groundbreaking Clinical Trial Data Demonstrates Clinical Remission of Peanut Allergy in Paediatric Patients
  • Groundbreaking New Clinical Trial Data Published in The Lancet Child & Adolescent Health
  • Data shows that 51% of participants achieved sustained unresponsiveness (clinical remission) to peanut after 18 months of treatment
  • Prota Therapeutics announces new round of capital raising for further P3 clinical investigation and global commercialization...

Read more: Prota Therapeutics Achieves Peanut Allergy Treatment Milestone: Groundbreaking Clinical Trial Data...

Business News

Manhari Founder, Maddy Gupta, urges businesses to capitalise on the rising value of metals

Old and unwanted equipment and business assets are often worth far more than they appear particularly those containing valuable metals. Precious metals, led by gold and silver reaching record highs...

Daily Bulletin - avatar Daily Bulletin

Qualities to Check in an NDIS Provider

Everyone wants to live life with independence and dignity. For people with disabilities, achieving this often requires the right support. This is where NDIS providers play an important role. These pro...

Daily Bulletin - avatar Daily Bulletin

How Thorough Component Inspections Protect Your Supply Chain from Costly Failures

In the modern world, where manufacturing has become highly interconnected, the weakest components of the supply chain can only make the chain as strong as it is. One defective component might cause ...

Daily Bulletin - avatar Daily Bulletin

Speed Dating For Business